12th Annual US-India BioPharma & Healthcare Summit, May 8, 2018, Marriott Cambridge

January 18, 2018 by 2012pharmaceutical

12th Annual US-India BioPharma & Healthcare Summit, May 8, 2018, Marriott Cambridge

Reporter: Aviva Lev-Ari, PhD, RN

http://usaindiachamber.org/speaker.php

@USAIC

#USAIC2018

Announcement

Aviva Lev-Ari, PhD, RN,

Founder and Director of LPBI Group will be in attendance covering the event in REAL TIME

@pharma_BI

@AVIVA1950

All TWEETS from LPBI’s Twitter.com handles at

@USAIC

#USAIC2018

@pharma_BI

@AVIVA1950

BioPharma & Healthcare Summit – May 8, 2018

Chair and Emcee – Dr. Andrew Plump, Chief Medical & Scientific Officer, Takeda Pharmaceuticals

Time	Topic
8-45 AM – 9-10 AM	Registration and Networking
9-10 AM – 9-25 AM	Welcome address: Karun Rishi, President, USA-India Chamber of Commerce (USAIC) Opening comments: Dr Andrew Plump, Chief Medical & Scientific Officer, Takeda Pharmaceuticals
9-25 AM – 10-15 AM	Panel Discussion: Industry-Academic Research Partnerships Panelists: Dr. Chas Bountra, Chief Scientist, Structural Genomics Consortium Oxford, University of Oxford Dr. Jim Glasheen, Executive Vice Chancellor, University of Massachusetts Medical School Dr. Jonathan Epstein, Executive Vice Dean & Chief Scientific Officer, Perelman School of Medicine, University of Pennsylvania Dr. Nirmal Kumar Ganguly, President, Apollo Hospitals Educational & Research Foundation Dr. Sridaran Natesan, Head – Strategic Initiatives & Scientific Relations, R&D, Sanofi North America Moderator: Juan Harrison, Vice President, Head of Strategic Academic Alliances, Takeda Pharmaceuticals
10-15 AM – 11-05 AM	Panel Discussion: Neuro Diseases Panelists: Dr. Alfred Sandrock, Executive Vice President & Chief Medical Officer, Biogen Dr. David Goldstein, Director, Institute for Genomic Medicine, Columbia University Medical Center Dr. Maurizio Fava, Associate Dean, Clinical & Translational Research, Harvard Medical School Dr. Meeta Chatterjee, Head, Business Strategy & Operations, Business Development & Licensing, Merck Research Labs Dr. Steven Paul, President and Chief Executive Officer, Voyager Therapeutics Moderator: Dr. Steve Uden, Co-Founder, Rallybio
11-05 AM -11-35 AM	Networking Break
11-35 AM – 12-25 PM	Panel Discussion: Oncology Panelists: Dr. Bruce Chabner, Director of Clinical Research, Mass General Hospital Cancer Center/Harvard Medical School Dr. Kurt Stoeckli, President and Chief Scientific Officer, Glenmark Pharmaceuticals Dr. Philip Rowlands, Head of the Oncology Therapeutic Area Unit, Takeda Pharmaceuticals Dr. Victoria Richon, President & CEO, Ribon Therapeutics Dr. Rakesh Jain, Director, E.L. Steele Laboratory of Tumor Biology, Mass General Hospital Cancer Center/HMS Moderator: Dr. Raju Kucherlapati, Professor of Genetics, Harvard Medical School
12-25 PM – 1-00 PM	Fireside Chat: Dr. Ansbert Gadicke, Founder & Managing Director, MPM Capital Dr. Stelios Papadopoulos, Chairman, Biogen Dr. Tsutomu Une, Senior Corporate Advisor, GCA Corporation Moderator: Dr. William Chin, Professor of Medicine, Emeritus, Harvard Medical School
1-00 PM – 2-40 PM	Luncheon Panel Discussion: Technology Platforms Panelists: Chris Benko, Co-Founder & CEO, Koneksa Health Colin Hill, Chairman & CEO, GNS Healthcare Dr. Peter Mueller, Chairman, BioXcel Therapeutics Dr. Shahram Ebadollahi, Vice President, Innovations & Chief Scientific Officer, IBM Watson Health Group, IBM Dr. Vijay Chandru, Chairman, Strand Life Sciences Moderator: Dr. Ajay Dhankhar, Senior Partner, McKinsey and Company
2-40 PM – 3-15 PM	Networking & Tea Break
3-15 PM – 3-35 PM	BioPharma: An Extraordinary Disruption Dr. Ajay Dhankhar, Senior Partner, McKinsey and Company Sastry Chilukuri, Partner, McKinsey and Company
3-35 PM – 4-30 PM	Panel Discussion: Drug Discovery and Development Panelists: Dr. Andrew Plump, Chief Medical & Scientific Officer, Takeda Pharmaceuticals Dr. Mathai Mammen, Global Head of R&D, Janssen Pharmaceutical- Johnson & Johnson Dr. Michael Ehlers, Executive Vice President and Head of Research & Development, Biogen Moderator: Dr. Martin Mackay, Co-Founder and CEO, Rallybio
4-30 PM – 5-05 PM	Fireside Chat: Dr. George Daley, Dean, Harvard Medical School Dr. Susan Hockfield, President Emerita & Professor of Neuroscience, Massachusetts Institute of Technology (MIT) Moderator: Dr Andrew Plump, Chief Medical and Scientific Officer, Takeda Pharmaceuticals
5-05 PM – 5-10 PM	Closing Remarks
5-10 PM – 6-30 PM	Cocktails & Networking Reception

*Luncheon Panel Discussion: Lunch will be served at the table at 12:50 PM. Panel will start at 1:40 PM

* Speaker and Timings subject to change

Some of the Speakers and Participants
Dr. Andrew Plump Chief Medical & Scientific Officer Takeda Pharmaceuticals	Dr. James Bradner President Novartis Institutes for BioMedical Research	Prof. Susan Hockfield President Emerita MIT	Dr. Mathai Mammen Global Head of R&D Janssen R&D	Dr. Stelios Papadopoulos Chairman- Biogen Chairman- Exelixis

Dr. Martin Mackay Co-Founder Rallybio	Dr. R.K. Vats* Additional Secretary Ministry of Health & Family Welfare	Dr. George Daley Dean Harvard Medical School	Sanat Chattopadhyay President- Merck Manufacturing Division Merck & Co.	Dr. Steven Paul President & CEO Voyager Therapeutics

Dr. Bruce Chabner Director of Clinical Research Mass General Hospital Cancer Center	Dr. Eswara Reddy* Drugs Controller General of India Ministry of Health & Family Welfare	Dr. William W. Chin Professor of Medicine, Emeritus Harvard Medical School	Dr. Alfred Sandrock Executive Vice President & CMO Biogen	Dr. Jonathan Epstein Executive Vice Dean & CSO Perelman School of Medicine, UPenn

Dr. Chas Bountra Chief Scientist Structural Genomics Consortium Oxford	Dr. Katherine Bowdish Head Sanofi Sunrise	Dr. Philip Rowlands Head of the Oncology TAU Takeda Pharmaceuticals	Dr. Sridaran Natesan Vice President- Strategic Initiatives Sanofi	Jim Gilbert Senior Partner Flagship Pioneering

Dr. Jim Glasheen Executive Vice Chancellor UMass Medical School	Dr. Steve Hitchcock Global Head of Research Takeda Pharmaceuticals	Dr. Victoria Richon President & CEO Ribon Therapeutics	Dr. Michael Ehlers Executive Vice President R&D Biogen	Prof. Nirmal Kumar Ganguly Former Director General ICMR

Dr. Rakesh Jain Prof. of Tumor Biology MGH/Harvard Medical School	Dr. Daniel Jay Dean- Sackler School Tufts University	Dr. Michael Mendelsohn Founder & Executive Chairman Cardurion Pharmaceuticals	Dr. Christiana Bardon Managing Director MPM Capital	Dr. Tsutomu Une Senior Corporate Advisor GCA Corporation

Dr. Maurizio Fava Associate Dean for Translational Research Harvard Medical School	Dr. Peter Mueller Chairman BioXcel Therapeutics	Dr. Anthony Muslin Head of Cardiovascular & Fibrosis Research Sanofi	Brad Margus Chief Executive Officer Cerevance	Dr. Steve Uden Co-Founder Rallybio

Dr. Kurt Stoeckli President & CSO Glenmark Pharmaceuticals	Dr. Shahram Ebadollahi Chief Science Officer IBM Watson Health Group	Dr. Carl Goldfischer Managing Director Bay City Capital	Philippe Lopes-Fernandes Senior Vice-President Merck KGaA, Darmstadt, Germany	Dr. Michael Cima Associate Dean of Innovation MIT School of Engineering

Benjamin Thorner Head of Business Dev & Licensing Merck Research Labs	Dr. Tal Zaks Chief Medical Officer Moderna Therapeutics	Dr. Mario Saltarelli SVP- Early Dev & Neurology Vertex Pharmaceuticals	Dr. Ole Isacson Professor of Neurology Harvard Medical School	Dr. Iman El-Hariry Chief Medical Officer ERYTECH

Dr. Raju Kucherlapati Professor of Genetics Harvard Medical School	Dr. Kimberly Wagner President & COO CiBO Technologies	Dr. Lex H.T. Van der Ploeg Chief Scientific Officer Rhythm Pharma	Dr. Christopher Wright Chief Development Officer Ironwood Pharmaceuticals	Dr. Iya Khalil Co-Founder & Exe. Vice President GNS Healthcare

Juan Harrison VP, Head of Strategic Academic Alliances Takeda Pharmaceuticals	Dr. Vijay Chandru Chairman Strand Life Sciences	Vikas Sinha Managing Director MPM Capital	Dr. David Goldstein Director-Institute for Genomic Medicine Columbia University Medical Center	Dr. Birgit Schoeberl Global Head Modeling & Simulation Novartis Institutes for BioMed Res.

Dr. Ajay Dhankhar Senior Partner McKinsey and Company	Dr. Markus Haeberlein Head of Discovery Alkermes	Dr. Ajay Nirula Vice President-Immunology Eli Lilly	Dr. Isabel Aznarez Co-Founder & Head of Biology Stoke Therapeutics	Dr. Harith Rajagopalan Co-Founder & CEO Fractyl

Dr. Christopher Locher Co-Founder & CEO Versatope Therapeutics	Colin Hill Co- Founder & Chairman GNS Healthcare	Dr. Thomas Schuetz Co-founder & CEO Compass Therapeutics	Constantine Chinoporos Chief Business Officer Boston Pharmaceuticals	Dr. Frank Bobe Entrepreneur-in-Residence Wyss Institute

Sanjiv Patel President & CEO Relay Therapeutics	Dr. Rhonda Kaufman Director Foresite Capital Management	Dr. Meeta Chatterjee Head- Business Strategy, BD&L Merck Research Laboratories	Vinay Ranade Head of Biosimilars Reliance Life Sciences	Dr. Robert Copeland Co Founder & President Accent Therapeutics

Winston Kung Chief Operating Officer PMV Pharma	Dr. Femida Gwadry-Sridhar Founder & CEO Pulse Infoframe	Dr. Barry Ticho Chief Medical Officer Stoke Therapeutics	Dr. Patrick Anquetil Chief Executive Officer Portal Instruments	John Ripple Chief Executive Officer Exonics Therapeutics

Dr. James Cassella Chief Development Officer Concert Pharmaceuticals	Chris Benko Co-Founder & CEO Koneksa Health	Dr. Stefan Scherer Head Early Dev, Strategy & Innovation Novartis	Dr. Michael Vasconcelles Chief Medical Officer Unum Therapeutics	Jeff Hackman Chief Operating Officer Novelion Therapeutics